- €155.90bn
- €202.32bn
- $62.58bn
Health Rounds: Experimental approach uses AI to eliminate cold storage for mRNA vaccines (updated)
Health Rounds: Experimental approach may eliminate cold storage requirement for mRNA vaccines
Brief: Pfizer Declares Q4 Dividend Of $0.43 Per Share
Vaxcyte down after starting $1 bln stock, convertible offerings
Factbox: Global healthcare companies invest billions to boost US presence
AstraZeneca to invest over $1 billion in Massachusetts, boost workforce (updated)
Vaxcyte shares surge as pneumococcal vaccine succeeds in late-stage trial (updated)
Vaxcyte shares surge as pneumococcal vaccine meets main trial goals
Vaxcyte surges on pneumococcal vaccine late-stage trial success
Brief: Pfizer Says Litfulo Safety Profile In NSV Consistent With Alopecia Areata
Factbox: Major drugmakers turn to China for licensing deals
US RESEARCH ROUNDUP-Arxis, Cigna, Vylor
Trump Medicare drug pricing model may apply to only four companies after exemptions
Florida Attorney General sues Pfizer and CEO over COVID-19 vaccine claims (updated)
Florida Attorney General sues Pfizer and CEO over COVID-19 vaccine claims
Brief: Florida Attorney General Files Lawsuit Against Pfizer And Its CEO Albert Bourla
Brief: Pfizer's Tilrekimig Shows Significant Skin Clearance in Phase 2 Atopic Dermatitis Study
Factbox: Weight-loss drug developers line up to tap lucrative market as competition heats up
Celcuity gains as breast cancer drug launches in US